Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

4BIO Capital

WebsiteLinkedInTwittercbCrunchbase
Status
ACTIVE
Global HQ
London, England, United Kingdom
Countries of investment
  • USA
  • United Kingdom
  • France
  • Japan
Investment stages
  • Seed
Industries
  • Pharmaceuticals
  • Biotechnology
About
4BIO Capital is an international venture capital firm specializing in the advanced therapies sector. They invest in and support early stage companies developing treatments in areas of high unmet medical need, focusing on cell and gene therapy, RNA based treatments, and targeted delivery platforms.
Min check size
$1M
Max check size
$5M
Fund size
NPS

Investment Thesis

4BIO Capital aims to address high unmet medical and social needs by investing in advanced therapies and life sciences. The firm targets companies that are pioneering breakthroughs in biotech and related fields, with a focus on highgrowth potential and high returns.
Lead investor
Co Invest
Number of exits
Preferred contact method

4BIO Capital Contacts Information

Primary contact

Secondary contact

Portfolio

Carisma Therapeutics

Code Biotherapeutics

ADC Therapeutics

Entact Bio

Redpin Therapeutics

Ascend Advanced Therapies

Beacon Therapeutics

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp